Search Tag: Coronavirus

ICU Management

COVID-19: Still Poorly Understood

2020 02 Oct

During the first few months of the coronavirus disease, it was being suggested that severe COVID-19 may represent a hyperimmune disorder, similar to secondary haemophagocytic lymphohistiocytosis (sHLH) and macrophage activation syndrome (MAS). Cytokine storm, elevated plasma levels, ferritin and inflammatory biomarkers are all typical signs of sHLH/MAS.... Read more

ICU Management

COVID-19 Case Presentations - A New York City Experience

2020 10 Sep

Date:  Sept 10, 2020  Duration:  90 minutes Speaker:  Dr. David Kaufman MD is a critical care physician. He is an expert at supervising multidisciplinary innovation and quality improvement and has participated in multiple clinical research projects. Some of Dr. Kaufman’s major research interests include fluid optimization and hemodynamics,... Read more

ICU Management

Volume 20 - Issue 2, 2020

2020 11 Aug

Change content default value Read more

ICU Management

Masimo Expands the Masimo SafetyNet™️ Solution with Continuous Body Temperature Measurement

2020 27 Jul

The Radius Tº™ Wearable Temperature Sensor Automates Remote Monitoring of Patient Temperature Status Masimo  today announced a significant expansion to the Masimo SafetyNet™ platform with the introduction of Radius Tº™, a wearable, wireless sensor that provides continuous body temperature measurements. By augmenting the already powerful Masimo... Read more

ICU Management

Getinge Receives 510(k) Clearance From US FDA For The Servo-air® Mechanical Ventilator

2020 07 Jul

Getinge has received 510(k) clearance from the US Food & Drug Administration (FDA) for the company’s Servo-air® mechanical ventilator, which is part of the Servo family that supports intensive care ventilation ever since the first model was introduced in 1971. "We are happy to be able to help clinicians in their endeavor to save lives by adding... Read more

ICU Management

What is the Relevance of Cytokine Storm to COVID-19?

2020 05 Jul

COVID-19, in its most severe form, leads to life-threatening pneumonia and acute respiratory distress syndrome (ARDS). In patients with this severity of the coronavirus, mortality rate can approach 40 to 50%.    The mechanism of COVID-19 induced lung injury is still vague, but the term cytokine storm is being used quite frequently in scientific publications... Read more

ICU Management

COVID-19: Effect of Convalescent Plasma Therapy on Time to Clinical Improvement

2020 12 Jun

A study was conducted to evaluate the difference in clinical outcomes in severe/life-threatening COVID-19 patients treated with standard treatment versus standard treatment and convalescent plasma therapy. Convalescent plasma is blood, liquid portion, from people who have recovered from COVID-19. Convalescent plasma has antibodies that the body... Read more

ICU Management

DOD to Fund a Clinical Trial of COVID-19 Treatment with ExThera’s Seraph 100 Blood Filter

2020 09 Jun

After encouraging preliminary results in the treatment of critically-ill COVID-19 patients at a military hospital in the United States and fourteen other hospitals in Europe, the Department of Defense has selected the Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) as one of its main interventions in a pivotal, US-based randomized controlled... Read more

ICU Management

Volume 20 - Issue 1, 2020

2020 19 May

Change content default value Read more

ICU Management

COVID -19 Challenges

2020 19 May

C oronavirus disease (COVID-19) continues to spread. While nations that were hit early are now seeing a flattening of the curve from mitigation strategies, countries that have been hit more recently continue to suffer. It is true that the majority of the population experiences mild symptoms of the disease, but age, comorbidity, and male sex are important... Read more